Growth Metrics

Zimmer Biomet Holdings (ZBH) Divestments (2021 - 2022)

Zimmer Biomet Holdings' quarterly Divestments came in at -$7.2 million in Q1 2022, up 49.3% year-on-year from -$4.8 million in Q1 2021, and up 67.57% quarter-over-quarter from -$22.2 million in Q4 2021.

Zimmer Biomet Holdings has reported Divestments for 2 years, with the latest figure at -$7.2 million in Q1 2022.

  • For the quarter ending Q1 2022, Divestments rose 49.3% year-over-year to -$7.2 million; the trailing twelve-month figure through Dec 2022 stood at -$7.2 million (up 88.06% YoY), and the FY2022 full-year result was -$7.2 million, up 88.06% from the prior year.
  • Divestments for Q1 2022 stood at -$7.2 million, up from -$22.2 million in the prior quarter.
  • The five-year high for Divestments was -$7.2 million in Q1 2022, with the low at -$22.2 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 -7.20 Mn
Dec 31, 2021 -22.20 Mn
Sep 30, 2021 -12.90 Mn
Jun 30, 2021 -11.00 Mn
Mar 31, 2021 -14.20 Mn